A new report accuses American drugmaker Moderna of prioritizing profits from COVID-19 vaccines by keeping poor countries waiting. The New York Times says the vaccine maker has sold most of its doses to wealthier nations. Only one million doses have gone to low-income countries...
During anAxios COVID-19 vaccine eventon May 19, both the CEO of Moderna and the CEO of Pfizer said that depending on the research being done on the efficacy and longevity of the vaccines, a booster shot could be needed between either eight to 12 months after the recipient’s initial...
Moderna launches COVID booster campaignHollan, MikePatient Care (Online)
COVID vaccine funding at the federal level has run dry. Now, the burden of covering vaccination costs has shifted to public and private health insurance plans. Are COVID Booster Shots Free for Everyone? Most immunizations, including the flu vaccine, are classified as apreventative care benefitun...
Massachusetts and some other states have already declared that adult residentscan get a boostershot if it's been at least six months since their last Moderna or Pfizer dose, or two months since their Johnson & Johnson vaccine shot. "This emergency use authorization comes at a critical time as...
Moderna's booster will come at half the dose of the original two shots. As for recipients of the single-shot J&J vaccine, a COVID-19 booster is recommended for everyone at least two months after their vaccination. That's because the J&J vaccine hasn't proved as protective as the t...
Moderna is gearing up to halve the dose of its COVID-19 vaccine, the US drugmaker said on Wednesday, so that it can also be used to combat variants and inoculate children.
After some of the CDC's advisers voiced concerns over Moderna's decision to use one vial for two different dose sizes, the company defended the move by citing the need to roll out booster shots in "the context of the pandemic." The company was still mulling changes to the vaccine's pack...
Currently a booster dose of the Moderna COVID-19 vaccine at the 50 microgram dose level is authorized by the FDA for emergency use in the United States for adults 18 years and older. Moderna said it continues to collect and monitor real-world data on its COVID-19 vaccine. Clinical trials...
U.S. Study Suggests COVID-19 Vaccines May Be Ineffective Against Omicron Without Booster More Reuters FILE PHOTO: Vials labelled "Moderna, Johnson & Johnson, Pfizer-BioNTech coronavirus disease (COVID-19) vaccine" are seen in this illustration picture taken May 2,...